A Content Analysis of Web Pages on “Weight-Loss Injections”
Author:
Open Access
- 28 March 2026
- journal article
- Published by Giresun Training and Research Hospital in Cerasus Journal of Medicine
- Vol. 3 (2) , 114-123
Abstract
Objective: In recent years, injectable glucagon-like peptide-1 (GLP-1) receptor agonists have gained widespread attention due to their effectiveness in obesity management. However, these agents are frequently presented in media using simplified and misleading terminology such as “weight loss injections,” which may create unrealistic expectations and encourage inappropriate or off-label use. This study aimed to evaluate the content and characteristics of online information about weight-loss injections from a public health and ethical health communication perspective.Methods: This descriptive study employed qualitative content analysis of publicly accessible Turkish-language web pages. Data were collected between October and November 2025 using a Google search. Web pages published by private hospitals, private clinics, blogs, and news websites that provided informational or promotional content were included. Textual content was analyzed for the presence of medical indications, contraindications, complications, and side effects, prescription warnings, scientific references, emphasis on medical supervision, and recommendations for lifestyle modification. Visual content was assessed in terms of gender representation, depicted body type, and the use of symbolic elements such as pen needles. Quantitative findings were summarized descriptively, and inductive qualitative analysis was conducted to identify prominent themes.Results: A total of 44 web pages were analyzed. Scientific references and warnings that the product should be obtained by prescription were frequently absent. Although most pages emphasized medical supervision and lifestyle changes, information on indications and contraindications was often incomplete. Visual analysis showed a predominance of female and normal-weight body representations, potentially reinforcing narrow body ideals. Qualitative analysis identified themes including medical legitimacy, social media influence, psychological risks, and concerns regarding unauthorized access.Conclusion: Online content related to “weight loss injections” demonstrates significant scientific, ethical, and communicative shortcomings. Improving the quality of digital health communication and reframing these agents as medical treatments rather than cosmetic solutions isKeywords
Funding Information
- This study did not receive any financial support or funding from any source.
This publication has 17 references indexed in Scilit:
- Semaglutide (Ozempic®) Use in Denmark 2018 Through 2023 ‒ User Trends and off-Label Prescribing for Weight LossClinical Epidemiology, 2024
- Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adultsThe Lancet, 2024
- Popularity of Surgical and Pharmacological Obesity Treatment Methods Searched by Google Users: the Retrospective Analysis of Google Trends Statistics in 2004–2022Obesity Surgery, 2023
- Exploring the nexus of binge eating disorder (BED), New Psychoactive Substances (NPS), and misuse of pharmaceuticals: charting a path forwardExpert Opinion on Pharmacotherapy, 2023
- Public Interest in the Off-Label Use of Glucagon-like Peptide 1 Agonists (Ozempic) for Cosmetic Weight Loss: A Google Trends AnalysisAesthetic Surgery Journal, 2023
- Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trialNature Medicine, 2022
- OBEZİTELİ BİREYLERİN GÖZÜNDEN TÜRKİYE’DE MEDYADA OBEZİTETOBIDER - International Journal of Social Sciences, 2022
- Tirzepatide Once Weekly for the Treatment of ObesityNew England Journal of Medicine, 2022
- Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or ObesityJAMA, 2021
- Once-Weekly Semaglutide in Adults with Overweight or ObesityNew England Journal of Medicine, 2021